Intergard silver grafts

Description

Designed to reduce the risk of infection related to graft, Intergard silver is antimicrobial first graft of the market.Antimicrobial effectiveness: the majority of vascular graft infections occur at the time of the implant or in the postoperative period inmediato.ta of products, which include Woven (fabric), Knitted (hatched) and UltraThin (ultra-thin) configurations.

Antimicrobial effectiveness: the majority of vascular graft infections occur at the time of the implant or in the immediate postoperative period. The release of the grafts silver intergard silver profile is designed so that it is more active during the initial 24 hours later to the implant, with continuous and important release for a period of 7 days.

The initial concentration of the surface in a graft sterile silver intergard silver shows efficacy against Staphylococcus aureus resistant to Methicillin (Methicillin-Resistant Staph Aureus, MRSA), p. aeruginosa and S. epidermidis, effectively continued against S. epidermidis after seven dias.2, 3 validated for use with rifampicin: is validated for use with load of rifampicin, which makes it the first choice for routine prophylactic use.